Establishment of the system eliminating amyloid-beta across the blood-brain barrier
Project/Area Number |
26461271
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Neurology
|
Research Institution | Yamaguchi University |
Principal Investigator |
SANO Yasuteru 山口大学, 医学(系)研究科(研究院), 助教 (20379978)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 血液脳関門 / アルツハイマー病 |
Outline of Final Research Achievements |
The clearance of amyloid β from the brain could be a novel therapeutic target for Alzheimer’s disease (AD). Although LRP1 and ABC transporters were the Aβ transporters at the blood-brain barrier (BBB), conflicting data exist regarding the contribution of these proteins to the clearance of Aß through the BBB. In this study, we examined the expression of LRP1, p-glycoprotein, ABCG2 in the human brain pericytes (HBPCT) and human brain microvascular endothelial cells (HBMECs) using real time PCR, western blot, and immunostaining analyses. LRP1 were mainly expressed in HBPCT, not HBMECs. On the other hand, P-glycoprotein and ABCG2 were predominantly expressed in HBMECs. In addition, we disclosed that RAP, an inhibitor of LRP1, deceased the uptake of FAM-Aβ40 into HBPCT cells. These results indicated that Aβ could be transported across not only HBMEC but also HBPCTs via these receptor and transporter.
|
Report
(4 results)
Research Products
(18 results)
-
[Journal Article] Establishment of a New Conditionally Immortalized Human Skeletal Muscle Microvascular Endothelial Cell Line2017
Author(s)
Sano, H. Sano, Y. Ishiguchi, E. Shimizu, F. Omoto, M. Maeda, T. Nishihara, H. Takeshita, Y. Takahashi, S. Oishi, M. Kanda, T.
-
Journal Title
Journal of Cellular Physiology
Volume: 印刷中
Issue: 12
Pages: 3286-3295
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.2016
Author(s)
Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM.
-
Journal Title
Neurol Neuroimmunol Neuroinflamm.
Volume: 4
Issue: 1
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Rituximab-associated Progressive Multifocal Leukoencephalopathy Derived from Non-Hodgkin Lymphoma: Neuropathological Findings and Results of Mefloquine Treatment2015
Author(s)
Sano Y, Nakano Y, Omoto M, Takao M, Ikeda E, Oga A, Nakamichi K, Saijo M, Maoka T, Sano H, Kawai M, Kanda T.
-
Journal Title
Internal Medicine
Volume: 54
Issue: 8
Pages: 965-970
DOI
NAID
ISSN
0918-2918, 1349-7235
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
[Presentation] ヒト筋微小血管内皮細胞の細胞生物学的特徴2015
Author(s)
佐野 泰照, 尾本 雅俊, 佐野 宏徳, 前田 敏彦, 安部 真彰, 西原 秀昭, 神田 隆
Organizer
第27回日本神経免疫学会学術集会
Place of Presentation
岐阜市(長良川国際会議場)
Year and Date
2015-09-15
Related Report
-
-
-
-